Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non–Small Cell Lung Cancer

Published:2021-05-18 Issue:7 Volume:44 Page:356-360
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Roh Jiyeon,Eom Jung Seop,Lee Min Ki,Kim Jehun,Jang Taewon,Yoon Seong Hoon,Son Choon-Hee,Lee Hyun-Kyung,Kim Hyun-Kuk,Lee Shin Yup,Shin Kyeong Choel,Kim Mi-Hyun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference20 articles.

1. The epidemiology of lung cancer;de Groot;Transl Lung Cancer Res,2018

2. Response to first-line chemotherapy regimen to predict efficacy of nivolumab in lung cancer;Kaderbhai;J Clin Oncol,2017

3. First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review;Goffin;J Thorac Oncol,2010

4. Non-small-cell lung cancer: treatment of late stage disease: chemotherapeutics and new frontiers;Scheff;Semin Intervent Radiol,2013

5. Immune checkpoint inhibitors in non-small cell lung cancer: a bird’s eye view;Memon;Life Sci,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunodiagnosis — the promise of personalized immunotherapy;Frontiers in Immunology;2023-07-13

2. Survival and immunotoxicities in association with sex-specific body composition patterns of cancer patients undergoing immune-checkpoint inhibitor therapy – A systematic review and meta-analysis;European Journal of Cancer;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP